GEMCAD 2103 – TIRANUS Phase II study of Atezolizumab plus Tiraglolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal
- Coordinador Dr. Cape Town.
GEMCAD 2201 – GUARDANT REVEAL Circulating tumor DNA as complementary tool to assess response to neoadjuvant therapy in locally advanced rectal cancer
- coordinators Dres. Guzman, de Lacy, Rivers, Ayuso, Maurel.
GEMCAD 2102 / PEMBROLA – Phase II trial of Pembrolizumab and Olaparib in homologous-recombination deficient (HRD) advanced colorectal cancer (CRC)./ PEMBROLA.
- Coordinadores: Dr.. Garcia Carbonero / Dr.. I am able to
- Centros participantes: 15
Gemcad 1802
- Phase II randomized, multicenter FOLFOX6m + Ac monoclonal (anti-EGFR o bevacizumab) alone or in combination with hepatic chemoembolization (Lifepearls-Irinotecan) in patients with limited metastatic colorectal cancer and liver disease with poor prognosis criteria.
- Coordinadores: Dr.. Estela Pineda / Dr. David Paez
- Centros participantes: 9
Gemcad 1703 – DUREC
- Phase II study of Durvalumab plus Total Neoadjuvant Therapy (TNT) in locally advanced rectal cancer.
- Coordinador: Dr. Jaume Capdevila
- Centros participantes: 10
Next opening